CSGALNACT2 and plasma cell myeloma: In addition, abnormal expression of CSGALNACT2 is associated with osteoarthritic of the knee [19], atherosclerosis [20], pediatric high-grade glioma [21], multiple myeloma [22] as well as colorectal cancer [23].